Namouni Fouad 4
4 · Vor Biopharma Inc. · Filed May 2, 2024
Insider Transaction Report
Form 4
Namouni Fouad
Director
Transactions
- Award
Stock Option (right to buy)
2024-04-30+60,000→ 60,000 totalExercise: $1.72Exp: 2034-04-29→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The shares shall vest and become exercisable in a series of 36 successive equal monthly installments beginning on April 30, 2024, in each case subject to the Reporting Person's continued service as of each such date.